Impact of histological and molecular subtype on the potential therapeutic effect of buparlisib in canine mammary gland tumours
{{output}}
This study aims to evaluate the response of primary cells to buparlisib, a PI3K inhibitor, at varying concentrations and exposure durations across different histological and molecular subtypes of CMGTs, and to assess PI3K/Akt/mTOR pathway activity by measuring... ...
